Low-density lipoprotein metabolism in mice with soft tissue tumours.
This study examines the potential value of low-density lipoprotein (LDL) as a vehicle for directing cytotoxic drugs to tumour cells in mouse model systems. Control and MAC 13 tumour-bearing NMRI mice were injected with tracer doses of 125I-labelled native and cyclohexanedione-modified 131I-labelled LDL. 18 h later the animals were killed and the radioactivities assimilated by various tissues were measured relative to plasma activity at the time of death. These values were used to calculate specific tissue receptor-mediated LDL uptake. All tissues expressed receptors but the liver and adrenal gland were particularly active. In tumour-inoculated animals, the neoplastic lesions were second only to liver in their net assimilation of LDL. CFLP mice bearing virus-induced parotid adenomata gave results similar to those obtained in NMRI animals. In order to improve the selectivity of LDL assimilation we attempted to downregulate LDL receptors in the liver and adrenal gland by administration of the bile acid sodium taurocholate or by subcutaneous injection of hydrocortisone sodium succinate. These manoeuvres together reduced uptake of the lipoprotein into both organs without affecting tumour activity.
D000236:Adenoma / Q000378:metabolism*; D000818:Animals; D001692:Biological Transport; D002791:Cholesterol, Dietary / Q000494:pharmacology; D006854:Hydrocortisone / Q000494:pharmacology; D008077:Lipoproteins, LDL / Q000378:metabolism*; D051379:Mice; D008815:Mice, Inbred Strains; D011973:Receptors, LDL / Q000378:metabolism; D012983:Soft Tissue Neoplasms / Q000378:metabolism*; D013656:Taurocholic Acid / Q000494:pharmacology; D014018:Tissue Distribution
D002791:Cholesterol, Dietary; D008077:Lipoproteins, LDL; D011973:Receptors, LDL; D013656:Taurocholic Acid; D006854:Hydrocortisone